Navigation Links
FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension
Date:1/23/2012

HAMPTON, N.J., Jan. 23, 2012 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the use of inhaled nitric oxide (iNO) with the INOpulse® DS drug-delivery system as a combination product for pulmonary arterial hypertension (PAH). An investigational new drug application (IND) for PAH was submitted to the FDA in November 2011, and the company is pursuing clinical development under this open IND.

Nitric oxide is naturally produced by many cells in the human body, and is known as a "signaling molecule" due to its ability to penetrate cell membranes to deliver a signal to nearby muscles to relax.  When inhaled, nitric oxide selectively relaxes the cells of the pulmonary vasculature, resulting in increased blood flow through the lungs and delivery of more oxygenated blood to the body. Inhaled nitric oxide is available as INOMAX® (nitric oxide) for inhalation, a vasodilator, which, in conjunction with ventilation and other appropriate agents, treats term and near-term newborns (>34 weeks gestation) with hypoxic respiratory failure associated with evidence of pulmonary hypertension. 

Based on this use, Ikaria is investigating the use of iNO in patients with PAH, which is hypertension in the arteries between the heart and lungs.  The delivery of iNO will be pulsed to synchronize with the patient's breathing pattern through Ikaria's next-generation INOpulse® DS drug-delivery system, which is specially engineered for use in spontaneously breathing patients.  Ikaria's PAH development program, known as IK-7001, will investigate the use of iNO/INOpulse DS as a drug-device combination product.

"Our receipt of orphan drug designation for the use of iNO via the INOpulse in PAH, combined with the IND we submitted last yea
'/>"/>

SOURCE Ikaria, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Grants 510(k) Clearance to Curos® Disinfecting Port Protector
2. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. US Patent Office Grants COPAN Invention of Flocked Swabs
4. The European Commission Grants Marketing Authorization for DIFICLIR™ (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections
5. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
6. FDA Awards NIPTE Potential $35 Million in Grants to Reform Drug Manufacturing Process
7. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8. Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
9. Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants
10. FDA Grants Fast Track Designation to Bayers Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
11. Echo Therapeutics Announces Multiple Patents and Trademark Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... VANCOUVER, British Columbia , May 30, 2015 /PRNewswire/ ... today that results from a retrospective analysis of the ... therapy in men with metastatic castrate-resistant prostate cancer (CRPC) ... effect of clusterin inhibition in men at risk for ... in the trial had at least two of five ...
(Date:5/30/2015)... CAMBRIDGE, Massachusetts y SPARTANBURG ... 30, 2015 - Nueva ... clínico terapéutico para pacientes con cáncer en los ... Research Network y Molecular Health proporcionarán a los ...   La Guardian Research Network y ...
(Date:5/30/2015)... , May 30, 2015  Eisai Inc. announced today the ... that eribulin met the study,s primary endpoint evaluating overall survival ... (ADI), two types of advanced soft tissue sarcoma. These data ... of the American Society of Clinical Oncology (ASCO) in ... conference on Saturday, May 30, and also in an oral ...
Breaking Medicine Technology:OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 2OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 4OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 5OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 6Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6
... 2011 ConvaTec Healthcare, a world-leading developer, manufacturer and ... care, today announced that, following a review of current ... refinancing of its senior secured term loans originally entered ... ConvaTecConvaTec is a leading developer and marketer of innovative ...
... March 17, 2011 Giant Eagle®, the region,s leading ... Association,s (ADA) prestigious Chairman,s Citation Award. Giant ... which recognizes the outstanding accomplishments of individuals, corporations, institutions ... and have had a positive impact in advancing the ...
Cached Medicine Technology:ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans 2ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans 3Giant Eagle® Receives American Diabetes Association Chairman's Citation Award 2Giant Eagle® Receives American Diabetes Association Chairman's Citation Award 3
(Date:5/30/2015)... One of the pervasive problems plaguing the ... available. Often, the ruralness of a location can severely ... areas feeling the crunch of a strained healthcare system, ... paying high premiums and copays, Online USA Doctors ... via the power of the internet. , ...
(Date:5/30/2015)... Texas (PRWEB) May 30, 2015 EHO ... Services Web Portal that gives hospices the ability to ... industry. Because of this business model, EHO has been ... better pricing to its clients and survive among the ... with hospice management systems three years ago, it has ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 The Brain ... in coordination with ONEgeneration Senior Enrichment Center, headed by ... Raymond de Guzman and Brain Fitness Program Director Tee ... this event learned that there are many ways to ... Bar showed the residents the different ways to overcome ...
(Date:5/30/2015)... Key Housing, a top-rated corporate housing service ... June 2015 featured apartment community: 388 Beale Street. By ... Housing is helping those people looking for corporate housing ... the tightest apartment markets in the United States. , ... who requires temporary San Francisco corporate housing is going ...
(Date:5/30/2015)... May 30, 2015 A live auction ... medical equipment from hospitals, surgery centers and other medical ... will be sold including radiology, surgery, endoscopy, lab, anesthesia, ... will take place Tuesday, June 2nd starting at 10:00am ... located at 5025 North Hiatus Rd., Sunrise, FL 33351. ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 3Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 3Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2
... ... an employee responds falsely to a confirmation request. While paper confirmations make it difficult ... boards supporting the use of secure electronic confirmations now give companies a better way to ... ...
... Radical ... ... Skinny on Willpower! The publishing industry is in the midst of a revolutionary change, and nowhere ... On series. The series, recent hit, The Skinny On Willpower , addresses one of ...
... ... and advice from a qualified medical professional. Award-winning Board Certified New York City Plastic Surgeon, Dr. ... ... people, losing weight to achieve the ultimate healthy and fit body is a constant goal and ...
... ... R. Macdonald announced the launch of a new plastic surgery blog dedicated to real ... chronicle their cosmetic surgery experience through detailed daily accounts of their progress, and provide ... ...
... to change your drinking habits, researcher says , THURSDAY, May ... because of a reported link with a type of kidney cancer, ... , "The data in this study provide no concrete evidence of ... lead author, Nicholas Timpson, a lecturer in genetic epidemiology at the ...
... help urologic surgeons spare the neurovascular bundle (NVB) (which ... robotic assisted laparoscopic prostatectomy (RALP) for the treatment of ... at the ARRS 2010 Annual Meeting in San Diego, ... treatment of prostate cancer. "However it is limited by ...
Cached Medicine News:Health News:Brian Fox to Speak on Audit Confirmation Fraud at the 2010 IAPP Annual Forum and Expo 2Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 2Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 4Health News:Dr. Keith Berman's Beach Body Secrets: 7 Simple Tips for Weight Loss Success 2Health News:Dr. Keith Berman's Beach Body Secrets: 7 Simple Tips for Weight Loss Success 3Health News:San Francisco Plastic Surgeon Releases Plastic Surgery Patient Recovery Blog 2Health News:Study Disputes Link Between Milk and Kidney Cancer 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: